158 related articles for article (PubMed ID: 12590014)
1. Effects of bezafibrate and pravastatin on remnant-like lipoprotein particles and lipoprotein subclasses in type 2 diabetes.
Kazama H; Usui S; Okazaki M; Hosoi T; Ito H; Orimo H
Diabetes Res Clin Pract; 2003 Mar; 59(3):181-9. PubMed ID: 12590014
[TBL] [Abstract][Full Text] [Related]
2. Comparative study of bezafibrate and pravastatin in patients with coronary artery disease and high levels of remnant lipoprotein.
Sano K; Nakamura T; Hirano M; Kitta Y; Kobayashi T; Fujioka D; Saito Y; Yano T; Watanabe K; Watanabe Y; Mishina H; Obata JE; Kawabata K; Kugiyama K
Circ J; 2010 Aug; 74(8):1644-50. PubMed ID: 20574136
[TBL] [Abstract][Full Text] [Related]
3. Hypertriglyceridemia in pregnancy does not contribute to the enhanced formation of remnant lipoprotein particles.
Okazaki M; Usui S; Tokunaga K; Nakajima Y; Takeichi S; Nakano T; Nakajima K
Clin Chim Acta; 2004 Jan; 339(1-2):169-81. PubMed ID: 14687907
[TBL] [Abstract][Full Text] [Related]
4. Pravastatin compared to bezafibrate in the treatment of dyslipidemia in insulin-treated patients with type 2 diabetes mellitus.
Rustemeijer C; Schouten JA; Voerman HJ; Hensgens HE; Donker AJ; Heine RJ
Diabetes Metab Res Rev; 2000; 16(2):82-7. PubMed ID: 10751747
[TBL] [Abstract][Full Text] [Related]
5. Effects of bezafibrate on lipoprotein subclasses and inflammatory markers in patients with hypertriglyceridemia--a nuclear magnetic resonance study.
Ikewaki K; Noma K; Tohyama J; Kido T; Mochizuki S
Int J Cardiol; 2005 Jun; 101(3):441-7. PubMed ID: 15907413
[TBL] [Abstract][Full Text] [Related]
6. Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on remnant-like particle cholesterol from the MARINE and ANCHOR studies.
Ballantyne CM; Bays HE; Philip S; Doyle RT; Braeckman RA; Stirtan WG; Soni PN; Juliano RA
Atherosclerosis; 2016 Oct; 253():81-87. PubMed ID: 27596132
[TBL] [Abstract][Full Text] [Related]
7. Postprandial remnant-like lipoproteins in hypertriglyceridemia.
Ooi TC; Cousins M; Ooi DS; Steiner G; Uffelman KD; Nakajima K; Simo IE
J Clin Endocrinol Metab; 2001 Jul; 86(7):3134-42. PubMed ID: 11443178
[TBL] [Abstract][Full Text] [Related]
8. Bezafibrate Ameliorates Arterial Stiffness Assessed by Cardio-Ankle Vascular Index in Hypertriglyceridemic Patients with Type 2 Diabetes Mellitus.
Yamaguchi T; Shirai K; Nagayama D; Nakamura S; Oka R; Tanaka S; Watanabe Y; Imamura H; Sato Y; Kawana H; Ohira M; Saiki A; Shimizu N; Tatsuno I
J Atheroscler Thromb; 2019 Jul; 26(7):659-669. PubMed ID: 30584220
[TBL] [Abstract][Full Text] [Related]
9. Relation between RLP-triglyceride to RLP-cholesterol ratio and particle size distribution in RLP-cholesterol profiles by HPLC.
Okazaki M; Usui S; Tada N; Nakano T; Nakajima K
Clin Chim Acta; 2000 Jun; 296(1-2):135-49. PubMed ID: 10807977
[TBL] [Abstract][Full Text] [Related]
10. The role of circulating lipoprotein lipase and adiponectin on the particle size of remnant lipoproteins in patients with diabetes mellitus and metabolic syndrome.
Shirakawa T; Nakajima K; Yatsuzuka S; Shimomura Y; Kobayashi J; Machida T; Sumino H; Murakami M
Clin Chim Acta; 2015 Feb; 440():123-32. PubMed ID: 25445417
[TBL] [Abstract][Full Text] [Related]
11. Effect of bezafibrate treatment on the altered lipoprotein profiles in hypertriglyceridemic subjects.
Norioka M; Suzuki M; Ryomoto K; Ikebuchi M; Harano Y
J Atheroscler Thromb; 2000; 7(4):198-202. PubMed ID: 11521682
[TBL] [Abstract][Full Text] [Related]
12. Greater remnant lipoprotein cholesterol reduction with pitavastatin compared with pravastatin in HIV-infected patients.
Joshi PH; Miller PE; Martin SS; Jones SR; Massaro JM; D'Agostino RB; Kulkarni KR; Sponseller C; Toth PP
AIDS; 2017 Apr; 31(7):965-971. PubMed ID: 28121706
[TBL] [Abstract][Full Text] [Related]
13. Does pravastatin increase chylomicron remnant catabolism in postmenopausal women with type 2 diabetes mellitus?
Ng TW; Watts GF; Stuckey BG; Ching HL; Chan DC; Uchida Y; Sakai N; Yamashita S; Martins IJ; Redgrave TG; Barrett PH
Clin Endocrinol (Oxf); 2005 Dec; 63(6):650-6. PubMed ID: 16343099
[TBL] [Abstract][Full Text] [Related]
14. Improvement of endothelial dysfunction is mediated through reduction of remnant lipoprotein after statin therapy in patients with coronary artery disease.
Nakamura T; Uematsu M; Yoshizaki T; Kobayashi T; Watanabe Y; Kugiyama K
J Cardiol; 2020 Mar; 75(3):270-274. PubMed ID: 31500961
[TBL] [Abstract][Full Text] [Related]
15. A comparison of pravastatin and gemfibrozil in the treatment of dyslipoproteinemia in patients with non-insulin-dependent diabetes mellitus.
Schweitzer M; Tessier D; Vlahos WD; Leiter L; Collet JP; McQueen MJ; Harvey L; Alaupovic P
Atherosclerosis; 2002 May; 162(1):201-10. PubMed ID: 11947915
[TBL] [Abstract][Full Text] [Related]
16. The effect of bezafibrate on very low density lipoprotein (VLDL), intermediate density lipoprotein (IDL), and low density lipoprotein (LDL) composition in type 1 diabetes associated with hypercholesterolaemia or combined hyperlipidaemia.
Winocour PH; Durrington PN; Bhatagnar D; Ishola M; Mackness M; Arrol S; Anderson DC
Atherosclerosis; 1992 Mar; 93(1-2):83-94. PubMed ID: 1596307
[TBL] [Abstract][Full Text] [Related]
17. Remnant lipoproteinemia is a risk factor for endothelial vasomotor dysfunction and coronary artery disease in metabolic syndrome.
Nakamura T; Takano H; Umetani K; Kawabata K; Obata JE; Kitta Y; Kodama Y; Mende A; Ichigi Y; Fujioka D; Saito Y; Kugiyama K
Atherosclerosis; 2005 Aug; 181(2):321-7. PubMed ID: 16039286
[TBL] [Abstract][Full Text] [Related]
18. Are high density lipoprotein (HDL) and triglyceride levels relevant in stroke prevention?
Rizos E; Mikhailidis DP
Cardiovasc Res; 2001 Nov; 52(2):199-207. PubMed ID: 11684067
[TBL] [Abstract][Full Text] [Related]
19. Effects of bezafibrate therapy on subfractions of plasma low-density lipoprotein and high-density lipoprotein, and on activities of lecithin:cholesterol acyltransferase and cholesteryl ester transfer protein in patients with hyperlipoproteinemia.
Homma Y; Ozawa H; Kobayashi T; Yamaguchi H; Sakane H; Mikami Y; Mikami Y; Nakamura H
Atherosclerosis; 1994 Apr; 106(2):191-201. PubMed ID: 8060379
[TBL] [Abstract][Full Text] [Related]
20. Determinants of postprandial triglyceride and remnant-like lipoproteins in type 2 diabetes.
Tan KC; Tso AW; Ma OC; Pang RW; Tam S; Lam KS
Diabetes Metab Res Rev; 2005; 21(2):209-14. PubMed ID: 15386805
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
